Skip to main content
SpringerLink
Log in

rhEPO in patients with anemia and congestive heart failure

  • Chapter
Recombinant Human Erythropoietin (rhEPO) in Clinical Oncology

  • 901 Accesses

Abstract

Many patients with congestive heart failure (CHF) fail to respond to maximal CHF therapy and progress to end stage CHF with many hospitalizations, very poor quality of life, end stage renal failure, or die of cardiovascular complications within a short time. One factor that has generally been ignored in many of these people is the fact that they are often anemic.The anemia is due mainly to renal failure but also to the inhibitory effects of cytokines on the bone marrow. Anemia itself may further worsen the cardiac function and make the patients resistant to standard CHF therapies. Indeed anemia has been associated with increased severity of CHF, increased hospitalization, worse cardiac function and functional class, higher doses of diuretics, worsening of renal function and reduced quality of life. In both controlled and uncontrolled studies the correction of the anemia with recombinant human erythropoietin (rhEPO) and oral or intravenous (IV) iron is associated with improvement in all these parameters. EPO itself may also play a direct role in improving the heart unrelated to the improvement of the anemia. Anemia may also play a role in the worsening of coronary heart disease even without CHF.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Similar content being viewed by others

References

  1. Aessopos A, Deftereos S, Farmakis D, et al (2004) Cardiovascular adaptation to chronic anemia in the elderly. Echocardiographic study. Clin Invest Med 27: 265–273

    PubMed  Google Scholar 

  2. Anand IS, Chandrashekhar Y, Ferrari R, Poole-Wilson PA, Harris PC (1993) Pathogenesis of edema in chronic anemia: Studies of body water and sodium, renal function, haemodynamics and plasma hormones. Br Heart J 70: 357–362

    Article  CAS  PubMed  Google Scholar 

  3. Androne AS, Katz SD, Lund L, et al (2003) Hemodilution is common in patients with advanced heart failure. Circulation 107: 226–229

    Article  PubMed  Google Scholar 

  4. Arant CB, Wessel TR, Olson MB, et al (2004) Hemoglobin level is an independent predictor for adverse cardiovascular outcomes in women undergoing evaluation for chest pain. J Am Coll Cardiol 43: 2009–2014

    Article  CAS  PubMed  Google Scholar 

  5. Astor BC, Arnett DK, Brown A, Coresh J (2004) Association of kidney function with left ventricular morphology among African Americans: The Atherosclerotic Risk in Communities (ARIC) Study. Am J Kidney Dis 43: 836–845

    Article  PubMed  Google Scholar 

  6. Bleumink GS, Knetsch AM, Stirkenboom MCJM, et al (2004) Quantifying the heart failure epidemic: prevalence, incidence rate, lifetime risk and prognosis of heart failure. Eur Heart J 25: 1614–1619

    Article  PubMed  Google Scholar 

  7. Bolger AP, Doehner W, Sharma R, Coate JS, Anker S (2002) Anemia in chronic heart failure: The relationship to inflammatory cytokine production and prognostic importance. Circulation 106 [Suppl]: 2819A (Abstr)

    Article  Google Scholar 

  8. Bongartz LG, Cramer MJ, Doevendans PA, Joles JA, Braam B (2005) The severe cardiorenal syndrome: “Guyton revisited”. Eur Heart J 26: 11–17

    Article  PubMed  Google Scholar 

  9. Brucks S, Little WC, Chao T, et al (2004) Relation of anemia to diastolic heart failure and the effect on outcome. Am J Cardiol 93: 1055–1057

    Article  PubMed  Google Scholar 

  10. Butler J, Forman DE, Abraham WT, et al (2004) Relationship between heart failure treatment and development of worsening renal function among hospitalized patients. Am Heart J 147: 331–338

    Article  PubMed  Google Scholar 

  11. Collins AJ (2003) Anaemia management prior to dialysis: cardiovascular benefits and cost-benefit observations. Nephrol Dial Transplant 18 [Suppl 2]: ii2–ii6

    PubMed  Google Scholar 

  12. Comin-Colet J, Bruguera J, Garcia C, et al (2005) Effect on hospitalization and functional status of correction of mild anemia with subcutaneous erythropoietin and intravenous iron in patients with severe advanced chronic heart failure and mild renal dysfunction. Heart Failure Meeting of the European Society of Cardiology. Lisbon 2005. (Abstr)

    Google Scholar 

  13. Cowie MR, Mosterd A, Wood DA, et al (1997) The Epidemiology of heart failure. Eur Heart J 18: 208–225

    CAS  PubMed  Google Scholar 

  14. Das SR, Dries DL, Drazner MH, Yancy CW, Chae CU (2004) Low hematocrit is associated with risk of progression from ALVD to symptomatic heart failure. Am J Cardiol 2005, 96: 827–831

    Article  Google Scholar 

  15. Davis LE, Hohimer AR (1991) Hemodynamics and organ flow in fetal sheep subjected to chronic anemia. Am J Physiol 261: R152–R158

    Google Scholar 

  16. Davis LE, Hohimer R, Brace RA (1996) Changes in left thoracic lymph flow during progressive anemia in the ovine fetus. Am J Obstet Gynecol 174: 1469–1476

    Article  CAS  PubMed  Google Scholar 

  17. Deicher R, Horl WH (2004) Hepcidin: a molecular link between inflammation and anaemia. Nephrol Dial Transplant 19: 521–524

    Article  CAS  PubMed  Google Scholar 

  18. Delgado RM, Radovancevic R, van Rossem CC, Bracey A, Radovancevic R (2004) Effect of administration of recombinant human erythropoietin in heart failure patients. Eur Heart J 25 [Suppl 1]: 386A

    Google Scholar 

  19. Ezekowitz JA, McAlister FA, Armstrong PW (2003) Anemia is common in heart failure and is associated with poor outcomes: insights from a cohort of 12065 patients with new onset heart failure. Circulation 107: 223–225

    Article  PubMed  Google Scholar 

  20. Ezekowitz JA, McAlister FA, Armstrong PW (2005) The interaction among sex, hemoglobin and outcomes in a specialty heart failure clinic. Can J Cardiol 21: 165–171

    PubMed  Google Scholar 

  21. Felker GM, Gattis WA, Leimberger JD, et al (2003) Usefulness of anemia as a predictor of death and rehospitalization in patients with decompensated heart failure. Am J Cardiol 92: 625–628

    Article  PubMed  Google Scholar 

  22. Fink JC, Blahut SA, Reddy M, Light PD (2001) Use of erythropoietin before the initiation of dialysis and its impact on mortality. Am J Kidney Dis 37: 348–355

    Article  CAS  PubMed  Google Scholar 

  23. Forman DE, Butler J, Wang Y, et al (2004) Incidence, predictors of admission, and impact of worsening renal function among patients hospitalized with heart failure. J Am Coll Cardiol 43: 61–67

    Article  PubMed  Google Scholar 

  24. Golden JS, Fallick CC, Josephson SR, et al (2002) Baseline hematocrit predicts clinical outcomes in heart failure. Circulation 106 [Suppl]: 3358A (Abstr)

    Google Scholar 

  25. Gouva C, Nikolopoulos P, Ioannidis JPA, Siamopoulos KC (2004) Treating anemia early in renal failure slows the decline of renal function: A randomized controlled study. Kidney Int 66: 753–760

    Article  PubMed  Google Scholar 

  26. Gregory DD, Sarnak MJ, Konstam MA, Pereira B, Salem D (2003) Impact of chronic kidney disease and anemia on hospitalization expense in patients with left ventricular dysfunction. Am J Cardiol 92: 1300–1305

    Article  PubMed  Google Scholar 

  27. Grune T, Sommerburg O, Siems WG (2000) Oxidative stress in anemia. Clin Nephrol 53 [Suppl 1]: S18–S22

    CAS  PubMed  Google Scholar 

  28. Gurm HS, Lincoff AM, Kleiman NS, et al (2004) Double jeopardy of renal insufficiency and anemia in patients undergoing percutaneous coronary interventions. Am J Cardiol 94: 30–34

    Article  PubMed  Google Scholar 

  29. Hebert PC (2004) Physiological aspects of anemia. Crit Care Clin 20: 187–212

    Article  PubMed  Google Scholar 

  30. Herrera-Garza EH, Stetson SJ, Cubillos-Garzon A, Vooltich MT, Farmer JA, Torre-Amione G (1999) Tumor necrosis factor: A mediator of disease progression in the failing human heart. Chest 115: 1170–1174

    Article  CAS  PubMed  Google Scholar 

  31. Herzog CA, Muster HA, Li S, Collins AJ (2004) Impact of congestive heart failure, chronic kidney disease and anemia on survival in the Medicare population. J Card Fail 10: 467–472

    Article  PubMed  Google Scholar 

  32. Holland DC, Lam M (2000) Predictors of hospitalization and death among predialysis patients: a retrospective study. Nephrol Dial Transplant 15: 650–658

    Article  CAS  PubMed  Google Scholar 

  33. Hsu C-Y, McCullough CE, Curhan GC (2002) Epidemiology of anemia associated with chronic renal insufficiency among adults in the United States: Results from the Third National Health and Nutrition Examination Survey. J Am Soc Nephrol 13: 504–410

    Article  PubMed  Google Scholar 

  34. Hsu C-Y, McCullough CE, Curhan GC (2002) Iron status and hemoglobin level in chronic renal failure. J Am Soc Nephrol 13: 2783–2786

    Article  CAS  PubMed  Google Scholar 

  35. Hunt SA, Baker DW, Chin MC, et al (2001) ACC/AHA guidelines for the evaluation and management of chronic heart failure: Executive summary. J Am Coll Cardiol 38: 2101–2113

    Article  CAS  PubMed  Google Scholar 

  36. Ishani A, Weinhandl E, Zhao Z, et al (2005) Angiotensin-converting enzyme inhibitor as a risk factor for the development of anemia and the impact of incident anemia on mortality in patients with left ventricular dysfunction. J Am Coll Cardiol 45: 391–399

    Article  CAS  PubMed  Google Scholar 

  37. Iverson PO, Woldbaek PR, Tonnessen T, Christensen G (2002) Decreased hematopoiesis in bone marrow of mice with congestive heart failure. Am J Physiol Regul Integr Comp Physiol 282: R166–R172.

    Google Scholar 

  38. Johnson DB, Dell’Italia LJ (1996) Cardiac hypertrophy and failure in hypertension. Curr Opin Nephrol Hypertens 5: 186–191

    Article  CAS  PubMed  Google Scholar 

  39. Katz AM (1994) The cardiomyopathy of overload: An unnatural growth response in the hypertrophied heart. Ann Intern Med 121: 363–371

    CAS  PubMed  Google Scholar 

  40. Keane WF, Brenner BM, de Zeeuw D, et al (2003) The risk of developing end-stage renal disease in patients with type 2 diabetes and nephropathy: The RENAAL study. Kidney Int 63: 149–150

    Article  Google Scholar 

  41. Khan SS, Kazmi WH, Abichandani R, Tighiouart H, Pereira BJ, Kausz AT (2002) Health care utilization among patients with chronic kidney disease. Kidney Int 62: 229–236

    Article  PubMed  Google Scholar 

  42. Kikuchi M, Inagaki T (1999) Atrial natriuretic peptide in aged patients with iron deficiency anemia. Arch Gerontol Geriat 28: 105–115

    Article  CAS  Google Scholar 

  43. Knudsen CW, Vik-Mo H, Omland T (2005) Blood hemoglobin is an independent predictor of B-type natriuretic peptide levels. Clin Sci 109: 69–74

    Article  Google Scholar 

  44. Kooistra MP, Niemantverdriet EC, van Es A, et al (1998) Iron absorption in erythropoietin-treated haemodialysis patients: effects of iron availability, inflammation and aluminium. Nephrol Dial Transplant 13: 82–88

    Article  CAS  PubMed  Google Scholar 

  45. Kosiborod M, Smith GL, Radford MJ, Foody JM, Krumholz HM (2003) The prognostic importance of anemia in patients with heart failure. Am J Med 114: 112–119

    Article  PubMed  Google Scholar 

  46. Langston RD, Presley R, Flanders WD, McClellan WM (2003) Renal insufficiency and anemia are independent risk factors for death among patients with acute myocardial infarction. Kidney Int 64: 1398–1405

    Article  PubMed  Google Scholar 

  47. Lee PC, Kini AS, Ahsan C, Fisher E, Sharma SK (2004) Anemia is an independent predictor of mortality after percutaneous coronary intervention. J Am Coll Cardiol 44: 541–546

    Article  PubMed  Google Scholar 

  48. Levin A (2002) The relationship of hemoglobin level and survival: direct or indirect effects. Nephrol Dial Transplant 17 [Suppl 5]: 8–13

    Article  CAS  PubMed  Google Scholar 

  49. Levy D, Kenchaiah S, Larson MG, et al (2002) Long term trends in the incidence of and survival with heart failure. N Engl J Med 347: 1397–1402

    Article  PubMed  Google Scholar 

  50. Ludat K, Sommerburg O, Grune T, Siems WG, Riedel E, Hampl H (2000) Oxidation parameters in complete correction of renal anemia. Clin Nephrology 53 [Suppl 1]: S30–S35

    CAS  Google Scholar 

  51. Macdougall IC (1999) The role of ACE inhibitors and angiotensin II receptor blockers in the response to erythropoietin. Nephrol Dial Transplant 14: 1836–1841

    Article  CAS  PubMed  Google Scholar 

  52. Maiese K, Li F, Chong ZZ (2005) New avenues of exploration for erythropoietin. JAMA 293: 90–95

    Article  CAS  PubMed  Google Scholar 

  53. Mancini DM, Katz SD, Lang C, et al (2003) Effect of erythropoietin on exercise capacity in patients with moderate to severe chronic heart failure. Circulation 107: 294–299

    Article  CAS  PubMed  Google Scholar 

  54. McClellan WM, Langston RD, Presley R (2004) Medicare patients with cardiovascular disease have a high prevalence of chronic kidney disease and a high rate of progression to end-stage renal disease. J Am Soc Nephrol 15: 1912–1919

    Article  PubMed  Google Scholar 

  55. McKechnie RS, Smith D, Montoye C, et al (2004) Prognostic implications of anemia on in-hospital outcomes after percutaneous coronary interventions. Circulation 110: 271–277

    Article  PubMed  Google Scholar 

  56. McMurray JJV, Stewart S (2002) The burden of heart failure. Eur Heart J 4 [Suppl D]: D50–D58

    Article  Google Scholar 

  57. Means RT (1999) Advances in the anemia of chronic disease. Int J Hematol 70: 7–12

    PubMed  Google Scholar 

  58. Means RT (2004) Hepcidin and anaemia. Blood Rev 18: 219–225

    Article  PubMed  Google Scholar 

  59. Miller LW, Missov ED (2001) Epidemiology of heart failure. Cardiol Clin 19: 547–555

    Article  CAS  PubMed  Google Scholar 

  60. Nikolsky E, Aymong ED, Halkin A, et al (2004) Impact of anemia in patients with acute myocardial infarction undergoing percutaneous coronary intervention. J Am Coll Cardiol 44: 547–553

    Article  PubMed  Google Scholar 

  61. Nikolsky E, Mehran R, Lasic Z, et al (2005) Low hematocrit predicts contrast-induced nephropathy after percutaneous coronary intervention. Kidney Internat 67: 706–713

    Article  Google Scholar 

  62. Nordyke RJ, Kim JJ, Goldberg GA, et al (2004) Impact of anemia on hospitalization time, charges and mortality in patients with heart failure. Value in Health 7: 464–471

    Article  PubMed  Google Scholar 

  63. Novak B, Sumodi V, Bynane M, Fagnilli K, Hanna MA, Hixson E (2003) Anemia management in an outpatient heart failure center. J Card Fail 9 [Suppl 1]: Abstr 386

    Google Scholar 

  64. Odabas AR, Cetinkaya R, Selcuk Y, Keles S, Bilen H (2003) The effect of high dose Losartan on erythropoietin resistance in patients undergoing hemodialysis. Panminerva Med 45: 59–62

    CAS  PubMed  Google Scholar 

  65. Olivetti G, Lagrasta C, Quaini F, et al (1989) Capillary growth in anaemia induced ventricular remodelling in the rat heart. Circ Res 65: 1182–1192

    CAS  PubMed  Google Scholar 

  66. Olivetti G, Quaini F, Lagrasta C, et al (1992) Myocyte cellular hypertophy and hyperplasia contribute to ventricular wall modelling in anemia induced cardiac hypertrophy in rats. Am J Pathol 141: 227–239

    CAS  PubMed  Google Scholar 

  67. Packer M, Cohn JN, et al (1999) Consensus recommendations for the management of chronic heart failure. Am J Cardiol 83: 1A–38A

    Article  Google Scholar 

  68. Rakusan K, Cicutti N, Kolar F (2001) Effect of anemia on cardiac function, microvascular structure and capillary hematocrit in rat hearts. Am J Physiol Heart Circ Physiol 280: H1407–H1414

    CAS  PubMed  Google Scholar 

  69. Reinecke H, Trey T, Wellmann J, et al (2003) Hemoglobin-related mortality in patients undergoing percutaneous coronary interventions. Eur Heart J 24: 2142–2150

    Article  CAS  PubMed  Google Scholar 

  70. Rossi MA, Carillo SV (1983) Electron microscopic study on the cardiac hypertrophy induced by iron deficiency in the rat. Br J Exp Pathol 64: 373–387

    CAS  PubMed  Google Scholar 

  71. Sandgren E, Murray AM, Herzog CA, et al (2005) Anemia and new-onset congestive heart failure in the general Medicare population. J Card Fail 11: 99–105

    Article  PubMed  Google Scholar 

  72. Shapiro BP, Chen HH, Burnett JC, Redfield MM (2003) Use of plasma brain natriuretic peptide concentration to aid in the diagnosis of heart failure. Mayo Clin Proc 78: 481–486

    Article  CAS  PubMed  Google Scholar 

  73. Silverberg DS, Blum M, Agbaria Z, et al (1999) Intravenous iron for the treatment of predialysis anemia. Kidney Int 55 [Suppl 67]: S79–S85

    Article  Google Scholar 

  74. Silverberg DS, Blum M, Agbaria Z, et al (2001) The effect of IV iron alone or in combination with low dose erythropoietin in the rapid correction of anemia of chronic renal failure in the predialysis period. Clin Nephrol 55: 212–219

    CAS  PubMed  Google Scholar 

  75. Silverberg DS, Wexler D, Blum M, et al (2000) The use of subcutaneous erythropoietin and intravenous iron for the treatment of the anemia of severe, resistant congestive heart failure improves cardiac and renal function, functional cardiac class, and markedly reduces hospitalizations. J Am Coll Cardiol 35: 1737–1744

    Article  CAS  PubMed  Google Scholar 

  76. Silverberg DS, Wexler D, Blum M, et al (2001) Aggressive therapy of congestive heart failure and associated chronic renal failure with medications and correction of anemia stops or slows the progression of both diseases. Perit Dial Int 21 [Suppl 3]: S236–S240

    PubMed  Google Scholar 

  77. Silverberg DS, Wexler D, Blum M, et al (2003) The effect of correction of anemia in diabetics and nondiabetics with severe resistant congestive heart failure and chronic renal failure by subcuteanous erythropoietin and intravenous iron. Nephrol Dial Transplant 18: 141–146

    Article  CAS  PubMed  Google Scholar 

  78. Silverberg DS, Wexler D, Blum M, et al (2004) The interaction between heart failure, renal failure and anemia — the cardio-renal anemia syndrome. Blood Purif 22: 277–284

    Article  PubMed  Google Scholar 

  79. Silverberg DS, Wexler D, Blum M, et al (2005) Effects of treatment with EPO beta on outcomes in patients with anaemia and chronic renal failure. Kidney Blood Press Res 28: 41–47

    Article  CAS  PubMed  Google Scholar 

  80. Silverberg DS, Wexler D, Blum M, Iaina A (2003) The cardio-renal anemia syndrome: correcting anemia inpatients with resistant congestive heart failure can improve both cardiac and renal function and reduces hospitalization. Clin Nephrol 60 [Suppl 1]: S93–S102

    PubMed  Google Scholar 

  81. Silverberg DS, Wexler D, Blum M, Schwartz D, Wollman Y, Iaina A (2003) Erythropoietin should be part of congestive heart failure management. Kidney Int 64 [Suppl 87]: S40–S47

    Article  Google Scholar 

  82. Silverberg DS, Wexler, Iaina A (2004) The role of anemia in the progression of congestive heart failure. Is there a place for erythropoietin and intravenous iron? J Nephrol 17: 749–761

    CAS  PubMed  Google Scholar 

  83. Silverberg DS, Wexler, Sheps D, et al (2001) The effect of correction of mild anemia in severe, resistant congestive heart failure using subcutaneous erythropoietin and intravenous iron: A randomized controlled study. J Am Coll Cardiol 37: 1775–1780

    Article  CAS  PubMed  Google Scholar 

  84. Smith KJ, Bleyer AJ, Little WC, Sane DC (2003) The cardiovascular effects of erythropoietin. Cardiovasc Res 59: 538–548

    Article  CAS  PubMed  Google Scholar 

  85. St. Peter WL, Xue J, Ebben J, Collins A (2001) Pre-end stage renal disease erythropoietin use predicts hospitalization in the periods before and after end-stage renal disease diagnosis. J Am Soc Nephrol 12 [Suppl]: Abstr 1274

    Google Scholar 

  86. Tang WHW, Miller H, Partin M, et al (2003) Anemia in ambulatory patients with chronic heart failure: A single-center clinical experience derived from electronic medical records. J Am Coll Cardiol 41 [Suppl A]: 157A

    Article  Google Scholar 

  87. Thomas MC, MacIsaac RJ, Tsalamandris C (2004) Anemia in patients with type 1 diabetes. J Clin Endocrinol Metab 89: 4359–4363

    Article  CAS  PubMed  Google Scholar 

  88. Thomas MC, MacIsaac RJ, Tslalmandris C, Power D, Jerums G (2003) Unrecognized anemia in patients with diabetes. Diabetes Care 26: 1164–1169

    Article  PubMed  Google Scholar 

  89. Tsuji H, Nishino N, Kimura Y, et al (2004) Haemoglobin level influences plasma brain natriuretic peptide concentration. Acta Cardiol 59: 527–531

    Article  PubMed  Google Scholar 

  90. Uber PA, Park MH, Scott RL, Mehra MR (2003) B-type natriuretic peptide levels are closely associated with anemia in chronic heart failure independent of underlying renal function. J Card Fail 9 [Suppl 1]: 133A, (Abstr)

    Google Scholar 

  91. Valderabano F, Horl W, Macdougall IC, Rossert J, Rutkowski B, Wauters J-P (2003) Pre-dialysis survey on anemia management. Nephrol Dial Transplant 18: 89–100

    Article  Google Scholar 

  92. Van der Meer P, Voors AA, Lipsic E, Smilde TDJ, van Gilst WH, van Veldhuisen DJ (2004) Prognostive value of plasma erythropoietin on mortality in patients with chronic heart failure. J Am Coll Cardiol 44: 63–67

    Article  PubMed  Google Scholar 

  93. van der Meer P, Voors AA, Lipsic E, van Gilst WH, van Veldhuisen DJ (2004) Erythropoietin in cardiovascular diseases. Eur Heart J 13: 285–291

    Article  Google Scholar 

  94. Vaziri ND (2001) Erythropoietin and transferrin metabolism in nephrotic syndrome. Am J Kidney Dis 38: 1–8

    Article  CAS  PubMed  Google Scholar 

  95. Wahr JA (1998) Myocardial ischemia in anaemic patients. Br J Anaes 81 [Suppl]: 10–15

    Google Scholar 

  96. Wexler D, Silverberg DS, Sheps D, et al (2004) Prevalence of anemia in patients admitted to hospital with a primary diagnosis of congestive heart failure. Int J Cardiol 96: 79–87

    Article  PubMed  Google Scholar 

  97. Wu W-C, Rathore SS, Wang Y, Radford MJ, Krumholtz H (2001) Blood transfusion in elderly patients with acute myocardial infarction. N Engl J Med 345: 1230–1236

    Article  CAS  PubMed  Google Scholar 

  98. Xue JL, St. Peter WL, Ebben JP, Everson SE, Collins AJ (2002) Anemia treatment in the pre-ESRD period and associated mortality in elderly patients. Am J Kid Dis 40: 1153–1161

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Nephrology, Tel Aviv Medical Center, Tel Aviv, Israel

    Donald S. Silverberg MD, Adrian Iaina MD, S. Steinbruch, Y. Wollman & Doron Schwartz

  2. Department of Cardiology and Heart Failure Clinic, From the Department of Nephrology and Cardiology, Tel Aviv Medical Center, Tel Aviv, Israel

    Dov Wexler MD

Authors
  1. Donald S. Silverberg MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Dov Wexler MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Adrian Iaina MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. S. Steinbruch
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Y. Wollman
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Doron Schwartz
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Donald S. Silverberg MD .

Editor information

Editors and Affiliations

  1. Department of Internal Medicine (Cancer Research), West German Cancer Center, University Hospital of Essen, Essen, Germany

    Mohammad Resa Nowrousian

Rights and permissions

Reprints and permissions

Copyright information

© 2008 Springer-Verlag/Wien

About this chapter

Cite this chapter

Silverberg, D.S., Wexler, D., Iaina, A., Steinbruch, S., Wollman, Y., Schwartz, D. (2008). rhEPO in patients with anemia and congestive heart failure. In: Nowrousian, M.R. (eds) Recombinant Human Erythropoietin (rhEPO) in Clinical Oncology. Springer, Vienna. https://doi.org/10.1007/978-3-211-69459-6_33

Download citation

  • DOI: https://doi.org/10.1007/978-3-211-69459-6_33

  • Publisher Name: Springer, Vienna

  • Print ISBN: 978-3-211-25223-9

  • Online ISBN: 978-3-211-69459-6

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation